Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
50 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Melinta Therapeutics, Inc - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Melinta Therapeutics, Inc - Product Pipeline Review - 2016', provides an overview of the Melinta Therapeutics, Inc's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Melinta Therapeutics, Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Melinta Therapeutics, Inc - The report provides overview of Melinta Therapeutics, Inc including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Melinta Therapeutics, Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Melinta Therapeutics, Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Melinta Therapeutics, Inc's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Melinta Therapeutics, Inc - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Melinta Therapeutics, Inc's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Melinta Therapeutics, Inc Snapshot 5 Melinta Therapeutics, Inc Overview 5 Key Information 5 Key Facts 5 Melinta Therapeutics, Inc - Research and Development Overview 6 Key Therapeutic Areas 6 Melinta Therapeutics, Inc - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Melinta Therapeutics, Inc - Pipeline Products Glance 11 Melinta Therapeutics, Inc - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Melinta Therapeutics, Inc - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Melinta Therapeutics, Inc - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Melinta Therapeutics, Inc - Drug Profiles 15 delafloxacin 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 radezolid 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 RX-02 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 RX-04 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 RX-05 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 RXP-792 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 RXP-873 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 RXP-763 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 RXP-766 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 RXP-770 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 RXP-793 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 RXP-808 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Melinta Therapeutics, Inc - Pipeline Analysis 34 Melinta Therapeutics, Inc - Pipeline Products by Target 34 Melinta Therapeutics, Inc - Pipeline Products by Route of Administration 35 Melinta Therapeutics, Inc - Pipeline Products by Molecule Type 36 Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action 37 Melinta Therapeutics, Inc - Recent Pipeline Updates 38 Melinta Therapeutics, Inc - Dormant Projects 46 Melinta Therapeutics, Inc - Company Statement 47 Melinta Therapeutics, Inc - Locations And Subsidiaries 48 Head Office 48 Other Locations & Subsidiaries 48 Appendix 49 Methodology 49 Coverage 49 Secondary Research 49 Primary Research 49 Expert Panel Validation 49 Contact Us 49 Disclaimer 50
List of Tables Melinta Therapeutics, Inc, Key Information 5 Melinta Therapeutics, Inc, Key Facts 5 Melinta Therapeutics, Inc - Pipeline by Indication, 2016 7 Melinta Therapeutics, Inc - Pipeline by Stage of Development, 2016 9 Melinta Therapeutics, Inc - Monotherapy Products in Pipeline, 2016 10 Melinta Therapeutics, Inc - Phase III, 2016 11 Melinta Therapeutics, Inc - Phase II, 2016 12 Melinta Therapeutics, Inc - Preclinical, 2016 13 Melinta Therapeutics, Inc - Discovery, 2016 14 Melinta Therapeutics, Inc - Pipeline by Target, 2016 34 Melinta Therapeutics, Inc - Pipeline by Route of Administration, 2016 35 Melinta Therapeutics, Inc - Pipeline by Molecule Type, 2016 36 Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action, 2016 37 Melinta Therapeutics, Inc - Recent Pipeline Updates, 2016 38 Melinta Therapeutics, Inc - Dormant Developmental Projects,2016 46 Melinta Therapeutics, Inc, Other Locations 48
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.